ArticleClinical and experimental immunology2022

Tofacitinib treatment modulates the levels of several inflammation-related plasma proteins in rheumatoid arthritis and baseline levels of soluble biomarkers associate with the treatment response.

Atte Valli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.